{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:52:40Z","timestamp":1785725560889,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cca.2018.07.043","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T11:33:52Z","timestamp":1532864032000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer"],"prefix":"10.1016","volume":"486","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0147-9378","authenticated-orcid":false,"given":"Anna","family":"Carobene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5705-0517","authenticated-orcid":false,"given":"Elena","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Cucchiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasne K.","family":"Aarsand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"D\u00edaz-Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Fernandez-Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"R\u00f8raas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-5354","authenticated-orcid":false,"given":"Ferruccio","family":"Ceriotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2018.07.043_bb0005","unstructured":"Global Burden of Disease Cancer Collaboration, C. Fitzmaurice, C. Allen, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 3 (2017) 524."},{"key":"10.1016\/j.cca.2018.07.043_bb0010","first-page":"221","article-title":"The use of biomarkers in prostate Cancer screening and treatment","volume":"19","author":"Ashley","year":"2017","journal-title":"Rev Urol."},{"key":"10.1016\/j.cca.2018.07.043_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21037\/tau.2017.12.24","article-title":"Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices","volume":"77","author":"Kinsella","year":"2018","journal-title":"Transl Androl Urol."},{"key":"10.1016\/j.cca.2018.07.043_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10408368909106595","article-title":"Generation and application of data on biological variation in clinical chemistry","volume":"27","author":"Fraser","year":"1989","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2018.07.043_bb0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0009-9120(95)91342-Z","article-title":"A guide to the interpretation of serum prostate specific antigen levels","volume":"28","author":"Bunting","year":"1995","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2018.07.043_bb0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1258\/acb.2009.009006","article-title":"Reference change values: the way forward in monitoring","volume":"46","author":"Fraser","year":"2009","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2018.07.043_bb0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/clinchem\/45.3.321","article-title":"Analytical performance characteristics should be judged against objective quality specifications","volume":"45","author":"Fraser","year":"1999","journal-title":"Clin Chem."},{"key":"10.1016\/j.cca.2018.07.043_bb0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/00365519950185184","article-title":"Introduction: strategies to set global quality specifications in laboratory medicine","volume":"59","author":"Fraser","year":"1999","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2018.07.043_bb0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1515\/cclm-2015-0067","article-title":"Defining analytical performance specifications: consensus statement from the 1st strategic conference of the European Federation of Clinical Chemistry and Laboratory Medicine","volume":"53","author":"Sandberg","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2018.07.043_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/cclm-2016-0091","article-title":"Criteria for assigning measurands to models for analytical performance specifications","volume":"55","author":"Ceriotti","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2018.07.043_bb0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1515\/cclm-2014-1133","article-title":"Reliability of biological variation data available in an online database: need for improvement","volume":"53","author":"Carobene","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2018.07.043_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/cclm-2014-1141","article-title":"Biological variation - reliable data is essential","volume":"53","author":"Aarsand","year":"2015","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.cca.2018.07.043_bb0065","author":"Minchinela"},{"key":"10.1016\/j.cca.2018.07.043_bb0070","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1515\/cclm-2016-0035","article-title":"Sample collections from healthy volunteers for biological variation estimates' update: a new project undertaken by the working group on biological variation established by the European federation of clinical chemistry and laboratory medicine","volume":"54","author":"Carobene","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2018.07.043_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/jlpm.2017.08.13","article-title":"The European Biological Variation Study (EuBIVAS): delivery of updated biological variation estimates, a project by the Working Group on Biological Variation in the European Federation of Clinical Chemistry and Laboratory Medicine","volume":"2","author":"Carobene","year":"2017","journal-title":"J. Lab. Precis. Med."},{"key":"10.1016\/j.cca.2018.07.043_bb0080","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1373\/clinchem.2016.269811","article-title":"Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum","volume":"63","author":"Carobene","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2018.07.043_bb0085","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1373\/clinchem.2017.275115","article-title":"The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring","volume":"63","author":"Carobene","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2018.07.043_bb0090","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2018.288415","article-title":"The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin and glucose","author":"Aarsand","year":"2018","journal-title":"Clin Chem."},{"key":"10.1016\/j.cca.2018.07.043_bb0095","unstructured":"G.W.C. Snedecor, W.G. Cochran. Statistical methods. 8th ed. Iowa State University Press."},{"key":"10.1016\/j.cca.2018.07.043_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1469-1809.1941.tb02271.x","article-title":"The distribution of the largest of a set of estimated variances as a fraction of their total","volume":"11","author":"Cochran","year":"1941","journal-title":"Ann. Eugenics"},{"key":"10.1016\/j.cca.2018.07.043_bb0105","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.cca.2018.07.043_bb0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1373\/clinchem.2015.252296","article-title":"Biological variation: the effect of different distributions on estimated within-person variation and reference change values","volume":"62","author":"Roraas","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2018.07.043_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2307\/3001634","article-title":"Processing data for outliers","volume":"9","author":"Dixon","year":"1953","journal-title":"Biometrics"},{"key":"10.1016\/j.cca.2018.07.043_bb0120","series-title":"Analysis of Variance for Random Models","author":"Sahai","year":"2004"},{"key":"10.1016\/j.cca.2018.07.043_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12894-018-0344-5","article-title":"Cost implications of PSA screening differ by age","volume":"18","author":"Rao","year":"2018","journal-title":"BMC Urol."},{"key":"10.1016\/j.cca.2018.07.043_bb0130","first-page":"385","article-title":"Variation of free and total prostate-specific antigen levels: the effect on the percent free\/total prostate-specific antigen","volume":"121","author":"Nixon","year":"1997","journal-title":"Arch Pathol Lab Med."},{"key":"10.1016\/j.cca.2018.07.043_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1373\/clinchem.2017.281808","article-title":"The biological variation data critical appraisal checklist: a standard for evaluating studies on biological variation","volume":"64","author":"Aarsand","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2018.07.043_bb0140","first-page":"135","article-title":"Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology","volume":"30","author":"Panteghini","year":"1992","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.cca.2018.07.043_bb0145","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0022-5347(01)64711-6","article-title":"Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients","volume":"157","author":"Nixon","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.cca.2018.07.043_bb0150","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0022-5347(01)64708-6","article-title":"Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers","volume":"157","author":"Ornstein","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.cca.2018.07.043_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5301\/urologia.5000051","article-title":"Role of PSA-related variables in improving positive ratio of biopsy of prostate cancer within serum PSA gray zone","volume":"81","author":"Liu","year":"2014","journal-title":"Urologia"},{"key":"10.1016\/j.cca.2018.07.043_bb0160","doi-asserted-by":"crossref","first-page":"f2023","DOI":"10.1136\/bmj.f2023","article-title":"Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study","volume":"346","author":"Vickers","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2018.07.043_bb0165","unstructured":"N. Mottet, R.C.N. van den Bergh, E. Briers, L. Bourke, P. Cornford, M. De Santis et al.; Members of the EAU \u2013 ESTRO \u2013 ESUR \u2013SIOG prostate Cancer guidelines panel. EAU \u2013 ESTRO \u2013 ESUR \u2013 SIOG Guidelines on Prostate Cancer (Accessed April 2018) (https:\/\/uroweb.org\/guideline\/prostate-cancer\/)."},{"key":"10.1016\/j.cca.2018.07.043_bb0170","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1373\/clinchem.2004.046086","article-title":"Biological variation of total prostate-specific antigen: a survey of published estimates and consequence for clinical practice","volume":"81","author":"Sol\u00e9tormos","year":"2005","journal-title":"Clin. Chem."},{"issue":"Suppl3","key":"10.1016\/j.cca.2018.07.043_bb0175","first-page":"89","article-title":"Objective interpretation of results for tumour markers","volume":"34","author":"Browning","year":"1990","journal-title":"J Nucl Med Allied Sci."},{"key":"10.1016\/j.cca.2018.07.043_bb0180","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1464-410X.2010.09761.x","article-title":"Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer","volume":"107","author":"Christensson","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.cca.2018.07.043_bb0185","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/pros.20286","article-title":"Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden","volume":"65","author":"Bruun","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.cca.2018.07.043_bb0190","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1464-410X.2011.10663.x","article-title":"The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore longitudinal study of aging and the Johns Hopkins active surveillance program","volume":"109","author":"Nichols","year":"2012","journal-title":"BJU Int."},{"issue":"6A Suppl","key":"10.1016\/j.cca.2018.07.043_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(96)00607-3","article-title":"Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions","volume":"48","author":"Woodrum","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.cca.2018.07.043_bb0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/clinchem\/44.3.685","article-title":"Preanalytical determinants of total and free prostate-specific antigen and their ratio: blood collection and storage conditions","volume":"44","author":"Jung","year":"1998","journal-title":"Clin. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118303905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118303905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T23:08:00Z","timestamp":1604704080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118303905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":40,"alternative-id":["S0009898118303905"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.07.043","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}